First report of Candida bracarensis in Mexico: hydrolytic enzymes and antifungal susceptibility pattern

Folia Microbiologica
Rogelio de J Treviño-RangelGloria M González

Abstract

Candida bracarensis is an emerging cryptic species within the Candida glabrata clade. To date, little is known about its epidemiology, virulence, and antifungal susceptibility. This study documents the occurrence of C. bracarensis for the first time in Mexico and focuses on its in vitro production of hydrolytic enzymes, as well as antifungal susceptibility to echinocandins. This strain was isolated from a vaginal swab of a female with vulvovaginal candidosis; exhibited a very strong activity of aspartyl proteinase, phospholipase, and hemolysin; and was susceptible to caspofungin, anidulafungin, and micafungin (MIC = 0.031 μg/mL). Data obtained could contribute to the knowledge of the epidemiology and virulence attributes of this yeast as a fungal opportunistic human pathogen.

References

Sep 1, 1979·Postgraduate Medical Journal·R Hurley, J De Louvois
Jun 1, 1991·Mycopathologia·A ChakrabartiP Talwar
Jan 1, 1984·Methods in Enzymology·H Aebi
Jan 11, 2000·Clinical Microbiology Reviews·M A Ghannoum
Dec 2, 2000·Journal of Clinical Microbiology·M Slifkin
Jul 28, 2001·Journal of Clinical Microbiology·G LuoJ Y Yau
May 6, 2005·Journal of Clinical Microbiology·Sandra S RichterMichael A Pfaller
Aug 6, 2005·Journal of Clinical Microbiology·Julia Alcoba-FlórezMaría del Pilar Arévalo
Jan 13, 2006·International Journal of Systematic and Evolutionary Microbiology·Alexandra CorreiaCélia Pais
Jun 15, 2007·Lancet·Jack D Sobel
Jul 27, 2007·Journal of Clinical Microbiology·Shin-ichi FujitaMitsuhiro Kawano
Jan 18, 2008·Journal of Clinical Microbiology·Andrew M BormanElizabeth M Johnson
Jul 15, 2009·Critical Care : the Official Journal of the Critical Care Forum·Deborah J E MarriottUNKNOWN Australian Candidaemia Study
Oct 1, 2010·Journal of Clinical Microbiology·Thomas A WarrenSean X Zhang
Dec 24, 2010·Drugs·Sharon C-A ChenTania C Sorrell
Mar 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·Conrad L SchochUNKNOWN Fungal Barcoding Consortium Author List
Sep 18, 2012·Revista iberoamericana de micología·Leyre M López-SoriaMiguel Montejo
Mar 30, 2013·Diagnostic Microbiology and Infectious Disease·Cheshta SharmaAnuradha Chowdhary
Oct 18, 2013·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Jan 15, 2014·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Ghada N Al-Rawahi, Diane L Roscoe
Jun 25, 2014·Emerging Infectious Diseases·Dounia BitarFrançoise Dromer
Dec 19, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Jan 27, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Jan 28, 2016·Memórias do Instituto Oswaldo Cruz·Maria Helena Galdino Figueiredo-CarvalhoRosely Maria Zancopé-Oliveira
Feb 10, 2017·Archives of Toxicology·C C ChangS C-A Chen
Dec 31, 2017·Revista iberoamericana de micología·Rogelio de J Treviño-RangelGloria M González

❮ Previous
Next ❯

Citations

Aug 15, 2019·Revista Do Instituto De Medicina Tropical De São Paulo·María Del Rocío Reyes-MontesMaría Guadalupe Frías-De-León
Feb 13, 2020·Journal of Clinical Laboratory Analysis·Shuqian CaiXiaoyun Shan

❮ Previous
Next ❯

Datasets Mentioned

BETA
JN882343
MF187327.1
JN882340
JN882341

Methods Mentioned

BETA
biopsy
bronchoalveolar lavage

Software Mentioned

MEGA

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.